64 results
8-K
EX-4.1
RSLS
ReShape Lifesciences Inc.
29 Nov 23
Entry into a Material Definitive Agreement
4:05pm
.
a)No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
8-K
EX-4.3
RSLS
ReShape Lifesciences Inc.
5 Oct 23
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
4:05pm
in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior
424B4
sutbmpv 8l6pgs1l81mi
3 Oct 23
Prospectus supplement with pricing info
9:23am
8-K
EX-4.1
qzmrayo5nw 80uncimse
26 Apr 23
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
4:06pm
8-K
EX-4.2
kcelpg
26 Apr 23
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
4:06pm
424B5
6u9lj
24 Apr 23
Prospectus supplement for primary offering
9:06am
8-K
esvsygp6e
28 Dec 22
ReShape Lifesciences Announces 1-for-50 Reverse Stock Split
4:18pm
8-K
EX-4.2
xyot1do0ub pzc9xxh1
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
EX-99.1
nbyb1rh2
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
EX-4.1
0bb4r9tb100k
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am